Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxel as first-line treatment for advanced gastric cancer (OGSG0402): Final report. Intergroup Trial of Adjuvant Chemotherapy in ...
SAN DIEGO, CA--(Marketwired - Oct 24, 2017) - AttackIQ™, a leader in the emerging market of continuous security validation, today announced the general availability of its new FireDrill™ platform ...
Bio-Matrix Scientific Group Inc. has announced it has entered into a contract with Validation Systems, Inc. to complete and finalize its FDA Good Manufacturing Practices (cGMP) Quality Systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback